Prevalence and socioeconomic determinants of financial toxicity in patients undergoing breast cancer surgery in Canada: A cross-sectional study.
241 Background: Financial toxicity (FT) has now been established as a treatment-related harm in oncology, including among patients with breast cancer. However, the evidence base rests largely on data from the United States, where patient cost-sharing is substantial. Few studies have characterized FT in high-inc...